Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin
暂无分享,去创建一个
S. Willich | H. Katus | H. Völler | J. Müller-Nordhorn | K. Wegscheider | F. Sonntag | W. Meyer-Sabellek | Eberhard Windier | H. Englert